JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schepis, T.
Right arrow Articles by Kaufmann, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schepis, T.
Right arrow Articles by Kaufmann, P. A.
Journal of Nuclear Medicine Vol. 48 No. 9 1424-1430
© 2007 by Society of Nuclear Medicine

doi: 10.2967/jnumed.107.040758

Clinical Investigation

Added Value of Coronary Artery Calcium Score as an Adjunct to Gated SPECT for the Evaluation of Coronary Artery Disease in an Intermediate-Risk Population

Tiziano Schepis1, Oliver Gaemperli1, Pascal Koepfli1, Mehdi Namdar1, Ines Valenta1, Hans Scheffel2, Sebastian Leschka2, Lars Husmann2, Franz R. Eberli1, Thomas F. Luscher1, Hatem Alkadhi2 and Philipp A. Kaufmann1,3

1 Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland; 2 Institute of Diagnostic Radiology, University Hospital Zurich, Zurich, Switzerland; and 3 Zurich Center for Integrative Human Physiology, Zurich, Switzerland

Correspondence: For correspondence or reprints contact: Philipp A. Kaufmann, MD, Nuclear Cardiology, Cardiovascular Center, University Hospital Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland. E-mail: pak{at}usz.ch

The coronary artery calcium (CAC) score is a readily and widely available tool for the noninvasive diagnosis of atherosclerotic coronary artery disease (CAD). The aim of this study was to investigate the added value of the CAC score as an adjunct to gated SPECT for the assessment of CAD in an intermediate-risk population. Methods: Seventy-seven prospectively recruited patients with intermediate risk (as determined by the Framingham Heart Study 10-y CAD risk score) and referred for coronary angiography because of suspected CAD underwent stress 99mTc-tetrofosmin SPECT myocardial perfusion imaging (MPI) and CT CAC scoring within 2 wk before coronary angiography. The sensitivity and specificity of SPECT alone and of the combination of the 2 methods (SPECT plus CAC score) in demonstrating significant CAD (≥50% stenosis on coronary angiography) were compared. Results: Forty-two (55%) of the 77 patients had CAD on coronary angiography, and 35 (45%) had abnormal SPECT results. The CAC score was significantly higher in subjects with perfusion abnormalities than in those who had normal SPECT results (889 ± 836 [mean ± SD] vs. 286 ± 335; P < 0.0001). Similarly, with rising CAC scores, a larger percentage of patients had CAD. Receiver-operating-characteristic analysis showed that a CAC score of greater than or equal to 709 was the optimal cutoff for detecting CAD missed by SPECT. SPECT alone had a sensitivity and a specificity for the detection of significant CAD of 76% and 91%, respectively. Combining SPECT with the CAC score (at a cutoff of 709) improved the sensitivity of SPECT (from 76% to 86%) for the detection of CAD, in association with a nonsignificant decrease in specificity (from 91% to 86%). Conclusion: The CAC score may offer incremental diagnostic information over SPECT data for identifying patients with significant CAD and negative MPI results.

Key Words: coronary artery disease • coronary calcium score • gated SPECT • multislice CT

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2007 48: 11A-12A. [Full Text]  



This article has been cited by other articles:


Home page
Heart AsiaHome page
T Chua
The evolving role of molecular imaging for coronary artery disease: where do we stand today?
Heart Asia, March 6, 2009; 2009(2): 1 - 5.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.